Matches in SemOpenAlex for { <https://semopenalex.org/work/W1968719331> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W1968719331 endingPage "S39" @default.
- W1968719331 startingPage "S38" @default.
- W1968719331 abstract "Hydrogen sulfide is a gaseous signaling molecule which is produced in vivo by three enzymes such as cystathionine γ-lyase (CSE), cystathionine β- synthase (CBS) and 3-mercaptopyruvate sulfurtransferase (MST) from L-cysteine.CSE is the prime enzyme among others for sulfide production in vascular tissues of our body. Hydrogen sulfide is reported to have vasodilatory, anti–inflammatory, anti-oxidant, cytoprotective and pro-angiogenic effects. Sulfide production is decreased in diabetic condition. However, the molecular mechanisms of sulfide-mediated protection during chronic tissue ischemia in diabetic condition are completely unknown. To determine molecular mechanisms involved in hydrogen sulfide mediated cytoprotection during chronic tissue ischemia in diabetic condition. Hind limb ischemia was induced in 10 week old wild type, 42 week old Db/Db diabetic or 10–12 week old CSE knock out (CSEKO, n = 8, each group). PBS, 0.1, 0.5 and 1 mg/kg sodium sulfide (Na 2 S) was administered twice daily by retro-orbital injection. Hind limb perfusion was measured using a laser Doppler perfusion probe. SPY imaging was performed to determine the collateral formation in different time points. Capillary myofiber ratio was determined by NOVA Red staining with CD31 antibody. Mature vessel density and proliferation index were determined by the ratio of smooth muscle actin (SMA) to DAPI and Ki67 to DAPI positive areas respectively. TUNEL assay was measured to investigate the apoptosis. Nitric oxide (NO) was measured by NO analyzer (NOA). CPTIO (1 mg/kg/day) was injected intra-peritoneally to determine the effect of NO in sulfide induced ischemic angiogenesis. VEGF aptamer (50 mg/kg/day) was injected locally to the ischemic muscle to determine the role of VEGF in sulfide induced ischemic angiogenesis. Lastly, VEGF expression was determined by ELISA. Blood perfusion, blush rate by SPY imaging, angiogenic index, proliferation index and mature vessel density were significantly decreased in CSEKO mice compared WT mice indicating the role of sulfide on ischemic angiogeneis and arteriogenesis. Na 2 S dose dependently increases the angiogenesis index, proliferation index, mature vessel density and restores the blood flow in WT mice. Hydrogen sulfide also rescues the impaired blood flow in CSEKO mice by increasing angiogenic index, proliferation index and mature vessel density. Blood tissue perfusion, proliferation index, capillary to myofiber ratio and VEGF expression were all significantly increased and conversely, apoptosis was prevented in ischemic hind limbs of aged diabetic mice treated with Na 2 S compared to PBS control. There was no effect of sulfide on blood glucose, body weight and lipid profiles of diabetic mice.Total NO production was increased in sulfide treated group compared to PBS which was inhibited by CPTIO treatment. Lastly, VEGF164 aptamer blocked sulfide induced augmentation of blood flow and reduced the expression of VEGF164 in WT and diabetic mice hind limb ischemia indicating VEGF164 as the sulfide induced angiogenic stimulator. Sodium sulfide therapy restores tissue perfusion of critical limb ischemia by increasing production of NO, increasing expression of VEGF and preventing apoptosis in diabetic mouse chronic hind limb ischemia which may be beneficial for the diabetic patient with peripheral vascular disease." @default.
- W1968719331 created "2016-06-24" @default.
- W1968719331 creator A5013485864 @default.
- W1968719331 creator A5024890460 @default.
- W1968719331 creator A5028646111 @default.
- W1968719331 creator A5028708071 @default.
- W1968719331 creator A5040456439 @default.
- W1968719331 creator A5067696537 @default.
- W1968719331 date "2012-09-01" @default.
- W1968719331 modified "2023-09-24" @default.
- W1968719331 title "P61 Hydrogen sulfide therapy rescues critical limb ischemia in aged diabetic mice through NO/VEGF dependent pathway" @default.
- W1968719331 doi "https://doi.org/10.1016/j.niox.2012.08.062" @default.
- W1968719331 hasPublicationYear "2012" @default.
- W1968719331 type Work @default.
- W1968719331 sameAs 1968719331 @default.
- W1968719331 citedByCount "0" @default.
- W1968719331 crossrefType "journal-article" @default.
- W1968719331 hasAuthorship W1968719331A5013485864 @default.
- W1968719331 hasAuthorship W1968719331A5024890460 @default.
- W1968719331 hasAuthorship W1968719331A5028646111 @default.
- W1968719331 hasAuthorship W1968719331A5028708071 @default.
- W1968719331 hasAuthorship W1968719331A5040456439 @default.
- W1968719331 hasAuthorship W1968719331A5067696537 @default.
- W1968719331 hasConcept C126322002 @default.
- W1968719331 hasConcept C134018914 @default.
- W1968719331 hasConcept C16525657 @default.
- W1968719331 hasConcept C178790620 @default.
- W1968719331 hasConcept C181199279 @default.
- W1968719331 hasConcept C185592680 @default.
- W1968719331 hasConcept C187566844 @default.
- W1968719331 hasConcept C190283241 @default.
- W1968719331 hasConcept C196795494 @default.
- W1968719331 hasConcept C2777527632 @default.
- W1968719331 hasConcept C2777622882 @default.
- W1968719331 hasConcept C2779201268 @default.
- W1968719331 hasConcept C2780394083 @default.
- W1968719331 hasConcept C2780519940 @default.
- W1968719331 hasConcept C2780564542 @default.
- W1968719331 hasConcept C518881349 @default.
- W1968719331 hasConcept C519581460 @default.
- W1968719331 hasConcept C541997718 @default.
- W1968719331 hasConcept C55493867 @default.
- W1968719331 hasConcept C71924100 @default.
- W1968719331 hasConceptScore W1968719331C126322002 @default.
- W1968719331 hasConceptScore W1968719331C134018914 @default.
- W1968719331 hasConceptScore W1968719331C16525657 @default.
- W1968719331 hasConceptScore W1968719331C178790620 @default.
- W1968719331 hasConceptScore W1968719331C181199279 @default.
- W1968719331 hasConceptScore W1968719331C185592680 @default.
- W1968719331 hasConceptScore W1968719331C187566844 @default.
- W1968719331 hasConceptScore W1968719331C190283241 @default.
- W1968719331 hasConceptScore W1968719331C196795494 @default.
- W1968719331 hasConceptScore W1968719331C2777527632 @default.
- W1968719331 hasConceptScore W1968719331C2777622882 @default.
- W1968719331 hasConceptScore W1968719331C2779201268 @default.
- W1968719331 hasConceptScore W1968719331C2780394083 @default.
- W1968719331 hasConceptScore W1968719331C2780519940 @default.
- W1968719331 hasConceptScore W1968719331C2780564542 @default.
- W1968719331 hasConceptScore W1968719331C518881349 @default.
- W1968719331 hasConceptScore W1968719331C519581460 @default.
- W1968719331 hasConceptScore W1968719331C541997718 @default.
- W1968719331 hasConceptScore W1968719331C55493867 @default.
- W1968719331 hasConceptScore W1968719331C71924100 @default.
- W1968719331 hasLocation W19687193311 @default.
- W1968719331 hasOpenAccess W1968719331 @default.
- W1968719331 hasPrimaryLocation W19687193311 @default.
- W1968719331 hasRelatedWork W1968719331 @default.
- W1968719331 hasRelatedWork W1979710206 @default.
- W1968719331 hasRelatedWork W2077757343 @default.
- W1968719331 hasRelatedWork W2149461102 @default.
- W1968719331 hasRelatedWork W2349209355 @default.
- W1968719331 hasRelatedWork W2415329909 @default.
- W1968719331 hasRelatedWork W3028913142 @default.
- W1968719331 hasRelatedWork W3082698262 @default.
- W1968719331 hasRelatedWork W3119316657 @default.
- W1968719331 hasRelatedWork W3175397115 @default.
- W1968719331 hasVolume "27" @default.
- W1968719331 isParatext "false" @default.
- W1968719331 isRetracted "false" @default.
- W1968719331 magId "1968719331" @default.
- W1968719331 workType "article" @default.